中医临床研究
中醫臨床研究
중의림상연구
Clinical Journal of Chinese Medicine
2015年
28期
76-77
,共2页
重症肌无力%补中益气汤%泼尼松%疗效
重癥肌無力%補中益氣湯%潑尼鬆%療效
중증기무력%보중익기탕%발니송%료효
Myasthenia gravis%The Buzhong Yiqi decoction%Prednisone%Efficacy
目的:观察补中益气汤辨证加减联合激素治疗重症肌无力的疗效.方法:选择我院2013年2月-2014年5月收治的50例重症肌无力患者为研究对象,按照数字表格法将其分为两组,各25例,对照组给予单纯激素(泼尼松)治疗,治疗组给予补中益气汤辨证加减联合激素治疗,比较两组治疗效果及不良反应.结果:治疗组治愈率、不良反应发生率分别为 52.0%、4.0%,与对照组的 20.0%、24.0%比较,差异显著(P<0.05).结论:补中益气汤辨证加减联合激素(泼尼松)治疗重症肌无力安全有效,值得临床推广.
目的:觀察補中益氣湯辨證加減聯閤激素治療重癥肌無力的療效.方法:選擇我院2013年2月-2014年5月收治的50例重癥肌無力患者為研究對象,按照數字錶格法將其分為兩組,各25例,對照組給予單純激素(潑尼鬆)治療,治療組給予補中益氣湯辨證加減聯閤激素治療,比較兩組治療效果及不良反應.結果:治療組治愈率、不良反應髮生率分彆為 52.0%、4.0%,與對照組的 20.0%、24.0%比較,差異顯著(P<0.05).結論:補中益氣湯辨證加減聯閤激素(潑尼鬆)治療重癥肌無力安全有效,值得臨床推廣.
목적:관찰보중익기탕변증가감연합격소치료중증기무력적료효.방법:선택아원2013년2월-2014년5월수치적50례중증기무력환자위연구대상,안조수자표격법장기분위량조,각25례,대조조급여단순격소(발니송)치료,치료조급여보중익기탕변증가감연합격소치료,비교량조치료효과급불량반응.결과:치료조치유솔、불량반응발생솔분별위 52.0%、4.0%,여대조조적 20.0%、24.0%비교,차이현저(P<0.05).결론:보중익기탕변증가감연합격소(발니송)치료중증기무력안전유효,치득림상추엄.
Objective: To observe efficacy of the Buzhong Yiqi decoction plus hormone on myasthenia gravis. Methods: From February 2013 to May 2014, 50 cases of myasthenia gravis in our hospital were randomly divided into two groups, 25 cases for each. The control group was given the hormone (Prednisone) simply; and the treatment group was given the Buzhong Yiqi decoction plus hormone. The efficiency and adverse reactions in two groups were compared. Results: In the treatment group, the efficiency was 52.0%; and the incidence of adverse reactions was 4.0%. In the control group, the efficiency was 20.0%; and the incidence of adverse reactions was 24.0%. The difference was statistically significant (P<0.05). Conclusion: The Buzhong Yiqi decoction plus hormone on myasthenia gravis is safe and effective, and worthy of promotion.
